SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-075864
Filing Date
2024-03-25
Accepted
2024-03-25 06:06:55
Documents
18
Period of Report
2024-03-19
Items
Item 1.03: Bankruptcy or Receivership
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d813107d8k.htm   iXBRL 8-K 44475
2 EX-2.1 d813107dex21.htm EX-2.1 1237568
3 EX-99.1 d813107dex991.htm EX-99.1 255509
4 EX-99.2 d813107dex992.htm EX-99.2 12335
8 GRAPHIC g813107g0320192249550.jpg GRAPHIC 3546
9 GRAPHIC g813107g0322014232868.jpg GRAPHIC 24468
  Complete submission text file 0001193125-24-075864.txt   2025366

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA endp-20240319.xsd EX-101.SCH 2499
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE endp-20240319_lab.xml EX-101.LAB 15749
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endp-20240319_pre.xml EX-101.PRE 9901
21 EXTRACTED XBRL INSTANCE DOCUMENT d813107d8k_htm.xml XML 3247
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 24776813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)